Differential diagnosis of pharyngitis Main inflammatory throat diseases

Скачать презентацию Differential diagnosis of pharyngitis Main inflammatory throat diseases Скачать презентацию Differential diagnosis of pharyngitis Main inflammatory throat diseases

14036-diphtheria_tonsillitis_im.ppt

  • Количество слайдов: 63

>Differential diagnosis of pharyngitis Differential diagnosis of pharyngitis

>Main inflammatory throat diseases Pharyngitis Tonsillitis, tonsillopharyngitis Adenoiditis Paratonsillar abscess Retropharyngeal abscess Main inflammatory throat diseases Pharyngitis Tonsillitis, tonsillopharyngitis Adenoiditis Paratonsillar abscess Retropharyngeal abscess

>Classification of pharyngitis Catarrhal pharyngitis         Classification of pharyngitis Catarrhal pharyngitis - viral infections Exudative pharyngitis - at viral infections (adenovirus, ЕВV) - purulent-exudative (GAS) Membranous pharyngitis Diphtheria Пpseudomembranous pharyngitis EBV infection Lysteriosis Syphilis Leukemia Burnt pharyngitis Oropharyngeal candidosis Herpetic pharyngitis (НSV, enterovirus)

>Non-infectious pharyngitis SLE Kawasaki Syndrome Stivens-Johnson syndrome Leukemia Radiation damage Burnt pharyngitis Non-infectious pharyngitis SLE Kawasaki Syndrome Stivens-Johnson syndrome Leukemia Radiation damage Burnt pharyngitis

>Etiology of infectious pharyngitis Bacteria (35-30 %)  Group A Streptococcus (65-80%) Group C Etiology of infectious pharyngitis Bacteria (35-30 %) Group A Streptococcus (65-80%) Group C and G Streptococcus (5-10 %) Arcanobacterium haemolyticum Neisseria gonorrheae Corynebacterium diphtheriae Mycoplasma pneumoniae Chlamydia pneumoniae Francisella tularensis Coxiella burnetii Viruses (65-70 %) Rhinovirus Adenovirus Epstein-Barr virus Influenza Parainfluenza Enterovirus Herpes simplex virus Coronavirus RS-virus

>Clinics of viral pharyngitis Catarrhal pharyngitis Moderate sore throat, dryness Moderate pharyngeal hyperemia - Clinics of viral pharyngitis Catarrhal pharyngitis Moderate sore throat, dryness Moderate pharyngeal hyperemia - Follicular tonsillar hyperplasia - Serous exudate (+/-) at adenoviral and EBV infections Presence of other catarrhal signs: cough, rrhynitis, conjunctivitis Moderate fever Disease course 3-7 days

>Catarrhal pharyngitis Catarrhal pharyngitis

>Pharyngitis at primary HIV infection Incubation period is 3 to 5 weeks  Catarrhal Pharyngitis at primary HIV infection Incubation period is 3 to 5 weeks Catarrhal pharyngitis sometimes with ulcers Lymphadenopathy week before fever and pharyngitis Other signs of HIV infection: arthralgias, myalgias, macule-papule rash, drowsiness

>Pharyngitis at enteroviral infection Common signs: Season – summer (“summer flu”) High fever Mild Pharyngitis at enteroviral infection Common signs: Season – summer (“summer flu”) High fever Mild pharyngeal hyperemia Not typical: - tonsillar exudate, - cervical lymphadenitis Specific oropharyngeal signs : - herpangina – Сoxsackievirus A, B, Echovirus (papule-vesicles or nodules with hyperemia around on posterior pharyngeal wall, 1-2 mm, with further ulcers and disappearance 5-7 days later) - “hand-foot-mouth disease” - coxsackievirus A 16 (painful vesicles or ulcers in mouth cavity, on palms and soles; fever subfebrile)

>Herpangina at enteroviral infection Herpangina at enteroviral infection

>“Hand-foot-mouth disease”  coxsackievirus A 16 “Hand-foot-mouth disease” coxsackievirus A 16

>Primary herpetic gingivostomatitis Cause: HSV-1,2 In children under 5 years High fever Intense mouth Primary herpetic gingivostomatitis Cause: HSV-1,2 In children under 5 years High fever Intense mouth pain (possible dehydration) Ulcers in mouth: on lips, posterior pharynx, soft and hard palate Disease course 1-2 weeks

>Primary herpetic stomatitis Primary herpetic stomatitis

>Oral candidosis Oral candidosis

>Oral candidosis Oral candidosis

>Streptococcus Streptococcus

>Epidemiology of GAS  Source: sick, carrier  Ways of transmission:  Airborne, food-borne, Epidemiology of GAS Source: sick, carrier Ways of transmission: Airborne, food-borne, watery Season: Spring – Summer Susceptible group: children of 5-15 years

>Streptococcal (GAS) infection Classification of GAS – associated diseases  1.  Purulent diseases: Streptococcal (GAS) infection Classification of GAS – associated diseases 1. Purulent diseases: - respiratory infections; - skin and soft tissue infections; - systemic purulent infections. 2. Toxin – mediated infections (scarlet fever, TSS, erysipelas). Infectious – allergic complications (rheumatic fever, carditis, glomerulonephritis, PANDAS)

>Streptococcal pharyngitis Associated with hemolytic Streptococcus of groups А, С, G Fever 39.5 С Streptococcal pharyngitis Associated with hemolytic Streptococcus of groups А, С, G Fever 39.5 С and higher, chills Prominent throat pain and difficulty of swallowing PE: “burning throat”, uvualr edema, Yellowish purulent covers in lacunas or tonsillar follicules “Strawberry tongue” (papules + color) Tense and painful tonsillar lymph nodes

>Lacunar tonsillitis Lacunar tonsillitis

>Follicular tonsillitis Follicular tonsillitis

>Streptococcal tongue Streptococcal tongue

>Laboratory diagnosis of streptococcal pharyngitis Strep culture  Reaction with bacitracin (inhibit growth of Laboratory diagnosis of streptococcal pharyngitis Strep culture Reaction with bacitracin (inhibit growth of only GAS) Express tests: lattex agglutination, co-agglutination (Strep-test ) – determination of group polysaccharide antigen Detection of GAS DNA – (PCR, DNA-hybridization ) Titer of anti-streptolysin O – 2-3 weeks later. Diagnostic titer - 1:300

>GAS  is the only widely spread etiology of pharyngitis which requires antibiotic therapy GAS is the only widely spread etiology of pharyngitis which requires antibiotic therapy

>Antibiotics at streptococcal pharyngitis Penicillins (oral, parnetheral)  Cephalosporins of 1-2 generation  Macrolides Antibiotics at streptococcal pharyngitis Penicillins (oral, parnetheral) Cephalosporins of 1-2 generation Macrolides

>EВV infection  Infectious mononucleosis EВV infection Infectious mononucleosis

>Infectious mononucleosis  is caused by Epstain-Barr virus and is characterized by: Intoxication Acute Infectious mononucleosis is caused by Epstain-Barr virus and is characterized by: Intoxication Acute tonsillitis Generalized polylymphadenopathy, Hepatosplenomegaly

>Diseases with mononucleosis-like syndrome ЕВV infection – 90%      Diseases with mononucleosis-like syndrome ЕВV infection – 90% (infectious mononucleosis) СМV infection (cytomegaloviral mononucleosis) HIV infection Rubella Toxoplasmosis Viral hepatitis

>Etiology of EBV Family Herpesviridae – IV type DNA-containing   Target cells - Etiology of EBV Family Herpesviridae – IV type DNA-containing Target cells - В- and Т- lymphocytes Life-long persistense in B-cells Oncogenic (Berkitt’s lymphoma, nasopharyngeal carcinoma, CNS lymphoma at HIV infection)

>Epidemiology of EBV infection Way of transmission:      contact (saliva), Epidemiology of EBV infection Way of transmission: contact (saliva), sexual, hemotransfusions Children under 5 years – 80 % In 50 % asymptomatic After infection the person excretes the virus during 6 months; after – periodically through the life

>Pathogenesis of EBV infection Penetration and viral replication in pharyngeal mucosa Viremia  Infection Pathogenesis of EBV infection Penetration and viral replication in pharyngeal mucosa Viremia Infection of peripheral B-lymphocytes Uncontrolled prolipheration of B-cells (CBC – absolute lymphocytosis and ESR) Responsive production of T-cells supressors (СД8+) for inhibition of B-cell proliferation (CBC – atypical mononuclears) Depression of cellular immunity

>Clinics of EBV infection Fever  Lymphadenopathy Exudative pharyngitis (prominent)  Adenoiditis, nasal obstruction Clinics of EBV infection Fever Lymphadenopathy Exudative pharyngitis (prominent) Adenoiditis, nasal obstruction Hepatomegaly Possible exanthema

>Infectious mononucleosis Infectious mononucleosis

>Pharyngitis at infectious mononucleosis Pharyngitis at infectious mononucleosis

>Pharyngitis at infectious mononucleosis Pharyngitis at infectious mononucleosis

>Pharyngitis at infectious mononucleosis Pharyngitis at infectious mononucleosis

>Complications of EBV infection Respiratory tract obstruction (5-8%) Splenic rupture (0,5%) Neurologic disturbances: Complications of EBV infection Respiratory tract obstruction (5-8%) Splenic rupture (0,5%) Neurologic disturbances: - seizures, - Alice in Wonderland (metamorphopsia), - transverse myelitis, - facial paralysis, - meningitis (monocytic cytosis) Hematological: - hemolytic and aplastic anemia, - thrombocytopenia, - neutropenia (2-3rd wk of the disease)

>Laboratory diagnosis of EBV infection Heterophylic test (antibodies)     in children Laboratory diagnosis of EBV infection Heterophylic test (antibodies) in children older 6 years (1:28 - 1:56) Serologic – antibodies to early, capsid and nuclear antigens CBC: leucocytosis (leucopenia), lymphocytosis, atypical mononuclears, accelerated ESR. Increased activity of ALT

>Serological profile of EBV infection Serological profile of EBV infection

>Therapy of EBV infection NSAIDs (acetaminofen, ibuprofen) for fever Corticosteroids (on indications) Acyclovir – Therapy of EBV infection NSAIDs (acetaminofen, ibuprofen) for fever Corticosteroids (on indications) Acyclovir – questionable. Marcolides – for exudative purulent pharyngitis. Azythromycin 10 mg/kg/day – 5 days N.B.! Amoxicillin (ampicillin) is contraindicated

>Indications for corticosteroid therapy  Airway obstruction  Autoimmune hemolytic anemia  Thrombocytopenia Indications for corticosteroid therapy Airway obstruction Autoimmune hemolytic anemia Thrombocytopenia Hemorrhagic syndrome Seizures Meningitis

>25%-30% in childhood Most common – GAS Possible joining of anaerobic bacteria  Paratonsillar 25%-30% in childhood Most common – GAS Possible joining of anaerobic bacteria Paratonsillar abscess

>Symptoms Throat pain / dysphagia   5-7 days No effect from antibiotics Trismus Symptoms Throat pain / dysphagia 5-7 days No effect from antibiotics Trismus Pain at mouth opening Fever Muffled voice Pain irradiation into ear

>Oropharyngeal signs Assymetrical edema of soft tissue around tonsils with tonsillar dislocation Fluctuation by Oropharyngeal signs Assymetrical edema of soft tissue around tonsils with tonsillar dislocation Fluctuation by palpation Tonsils can be normal, or hyperemic, or covered with axudate Uvula is dislocated to healthy side Soft palate is hyperemic and edemstous Bilateral tonsillar involvement in 3% Malodor from mouth Cervical lymphadenopathy

>Treatment Penicillin G benzathine :  Adults - 600 mg (~1 million U) IV Treatment Penicillin G benzathine : Adults - 600 mg (~1 million U) IV q6h Children -12,500-25,000 U/kg IV q6h + Metronidazole (Flagyl) 15 mg/kg or 1 g per 70-kg adults IV during 1 hour supportive dosage: 6 h infusion 7.5 mg/kg or 500 mg per 70-kg adults during 1 hour every 6-8h; not more than 4 g/d Clindamycin – infants and children : 15-25 mg/kg/d PO every 8h; 25-40 mg/kg/d IV/IM every 8h Erythromycin

>Diphtheria Acute anthroponous disease, caused by Gram(+) toxigenic bacillus Corynebacterium diphtheria, characterized by local Diphtheria Acute anthroponous disease, caused by Gram(+) toxigenic bacillus Corynebacterium diphtheria, characterized by local fibrinous-inflammation of the mucus and/or skin, general intoxication and toxic complications: myocarditis, polyneuritis, nephrosis

>Etiology of diphtheria Gram(+) aerobic bacillus. Non-motile, non-encapsulated. Three variants: MITIS, GRAVIS and INTERMEDIUS. Etiology of diphtheria Gram(+) aerobic bacillus. Non-motile, non-encapsulated. Three variants: MITIS, GRAVIS and INTERMEDIUS. All variants of toxigenic Corynebacterium produce identical toxin. Non-toxigenic forms of Corynebacterium do not cause disease. Corynebacterium is resistant to low and high temperatures and drying. Situated in “X” or “V” pairs Corynebacterium can be resistant to erythromycin

>Epidemiology of diphtheria Season – cold   Source – sicka and carriers Epidemiology of diphtheria Season – cold Source – sicka and carriers Transmission – airborne 70% population vaccination prevents epidemics

>Pathogenesis of diphtheria Pathogenesis of diphtheria

>Classification of diphtheria Diphtheria of tonsils  Diphtheria of nose  Diphtheria of larynx Classification of diphtheria Diphtheria of tonsils Diphtheria of nose Diphtheria of larynx (croup, laryngitis) Diphtheria of eye Diphtheria of skin

>Clinics of diphtheria Incubational period = 2-10 days Acute disease onset Intoxication:  Clinics of diphtheria Incubational period = 2-10 days Acute disease onset Intoxication: moderate fever, headache, weakness Fibrinous pharyngitis Anterior cervical lymphadenitis Subcutaneous cervical tissue edema (+/-)

>Membranous pharyngitis Cyanotic hyperemia of pharynx  Tonsillar edema  Thick whitish-grayish covers, removed Membranous pharyngitis Cyanotic hyperemia of pharynx Tonsillar edema Thick whitish-grayish covers, removed with bleeding of mucosa Are formed by 3rd day of diphtheria

>Pharyngeal diphtheria Pharyngeal diphtheria

>Pharyngeal diphtheria Pharyngeal diphtheria

>Tonsillar diphtheria Tonsillar diphtheria

>Tonsillar diphtheria Tonsillar diphtheria

>Symptoms of severe diphtheria Toxic neck edema  Hemorrhagic syndrome  Shock (tachycardia, hypotension, Symptoms of severe diphtheria Toxic neck edema Hemorrhagic syndrome Shock (tachycardia, hypotension, oliguria)

>Neck edema at diphtheria Neck edema at diphtheria

>Complications of diphtheria  Myocarditis   Neuropathies   Nephritis Complications of diphtheria Myocarditis Neuropathies Nephritis

>Diagnosis of diphtheria Culture of С.diphtheriae with detection of toxigenicity  Detection of antibodies Diagnosis of diphtheria Culture of С.diphtheriae with detection of toxigenicity Detection of antibodies in reaction of neutralization (protective level is 0,5 U\ml) Detection of antibodies in reaction of direct hemagglutination (protective level is 1:320) Detection of phage (PCR) Detection of toxin in blood serum CBC: leucocytosis, neutrophilosis, accelerated ESR At neuropathies – elevation of protein in CSF

>Therapy of diphtheria Antitoxin (serum):        Minimal dosage: Therapy of diphtheria Antitoxin (serum): Minimal dosage: 20 - 40 thousand U Maximal dosage: 150 thousand U Route of injection: IM, IV Antibiotics (erythromycin, penicillin - 14 days)

>Prophylaxis of diphtheria Vaccination with diphtheria anatoxin  - V1:   3, Prophylaxis of diphtheria Vaccination with diphtheria anatoxin - V1: 3, 4, (+\-) 5 months - V2: 15 - 18 months - V3: 4 - 6 years - Later – every 10 years

>Prophylaxis of contacts and carriers Erythromycin or penicillin -7 days  Booster dose of Prophylaxis of contacts and carriers Erythromycin or penicillin -7 days Booster dose of anatoxin Throat culture Control throat culture 24 hours after antibiotic course